Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Jan. 31, 2021
Jan. 31, 2020
Reconciliation of net loss to net cash used in operating activities:    
Net loss $ (2,232,377) $ (2,616,575)
Stock option compensation to employees and directors 874,862 963,880
Stock options and warrants issued to consultants 111,237 57,454
Depreciation of property and equipment 14,998
Gain on sale of equipment (5,447)
Amortization of operating lease right-to-use asset 14,128 12,314
Change in operating assets and liabilities:    
Prepaid expenses and other current assets (269,757) 74,698
Accounts payable 279,448 (218,719)
Accrued expenses 71,810 (190,464)
Operating lease liability (14,362) (12,002)
Net cash used in operating activities (1,170,458) (1,914,416)
Cash flows from investing activities:    
Disbursements to acquire short-term investments in certificates of deposit (1,000,000) (1,870,000)
Proceeds from maturities of short-term investments in certificates of deposit 1,640,000 1,350,000
Purchase of property and equipment (15,790)
Proceeds from sale of equipment 35,447
Net cash provided by (used in) investing activities 675,447 (535,790)
Cash flows from financing activities:    
Net proceeds from sale of common stock in at-the-market offering 5,956,596 1,751,983
Proceeds from exercise of stock options 104,224 28,480
Net cash provided by financing activities 6,060,820 1,780,463
Net increase (decrease) in cash and cash equivalents 5,565,809 (669,743)
Cash and cash equivalents at beginning of period 6,417,061 3,491,625
Cash and cash equivalents at end of period 11,982,870 2,821,882
Supplemental cash flow information:    
Cash proceeds from interest income $ 1,134 $ 14,468